episod
wheez
becom
less
frequent
child
grow
older
howev
question
still
remain
whether
initi
episod
wheez
viral
respiratori
ill
import
factor
eventu
develop
asthma
although
signific
bodi
inform
suggest
associ
respiratori
tract
ill
earli
life
later
develop
airway
dysfunct
relationship
difficult
establish
indic
complex
factor
surround
develop
bronchial
hyperrespons
eventu
express
asthma
furthermor
sourc
subject
studi
ie
followup
hospit
patient
vs
outpati
contribut
difficulti
understand
problem
eisen
bacap
found
children
hospit
bronchiol
prior
age
year
increas
risk
asthma
rooney
william
also
evalu
retrospect
record
infant
hospit
bronchiol
month
younger
allerg
manifest
famili
histori
asthma
frequent
children
eventu
experienc
one
episod
wheez
final
mcconnochi
roghmann
identifi
patient
bronchiol
month
younger
compar
outcom
children
without
histori
bronchiol
children
evalu
approxim
year
later
upper
respiratori
allergi
bronchiol
passiv
smoke
exposur
found
independ
predictor
wheez
follow
bronchiol
consequ
appar
final
conclus
relationship
respiratori
infect
infanc
later
asthma
must
consid
host
influenc
includ
parent
smoke
underli
airway
respons
gender
similarli
import
issu
resolv
relationship
respiratori
infect
pathogenesi
airway
hyperrespons
evalu
effect
bronchiohti
airway
respons
sim
et
al
identifi
children
respiratori
syncyti
viru
rsv
respiratori
infect
quantit
bronchial
labil
exercis
test
compar
appropri
control
fall
peak
flow
exercis
greater
children
bronchiol
howev
airway
reactiv
exercis
differ
children
without
subsequ
episod
wheez
sinc
variabl
confound
studi
sim
et
al
could
prove
respiratori
infect
led
later
develop
asthma
effort
made
ascertain
viral
lower
respiratori
tract
infect
lri
earli
life
caus
persist
pulmonari
function
abnorm
pullan
hey
evalu
children
admit
hospit
first
year
life
rsv
lri
hospit
children
futur
episod
wheez
control
subject
experienc
similar
airway
symptom
howev
patient
vs
control
troublesom
respiratori
symptom
year
age
furthermor
although
threefold
increas
bronchial
respons
found
children
bronchiol
atopi
increas
analog
conclus
reach
weiss
et
al
assess
outcom
anteced
acut
respiratori
ill
airway
respons
atopi
young
adult
airway
respons
evalu
eucapn
hyperventil
subfreez
air
increas
children
previou
histori
either
croup
bronchiohti
greater
two
acut
lower
respiratori
ill
possibl
also
rais
predisposit
wheez
infanc
depend
intrins
airway
structur
atopi
posit
support
high
degre
airway
respons
found
infanc
physiolog
evalu
incid
wheez
respiratori
infect
howev
difficult
precis
assess
airway
respons
young
children
due
limit
lung
size
agerel
factor
help
clarifi
relationship
premorbid
lung
function
wheez
respiratori
ill
martinez
et
al
conduct
prospect
studi
respiratori
ill
infanc
childhood
lung
function
valu
determin
prior
lri
includ
measur
tidal
expiratori
pattern
specif
time
peak
tidal
expiratori
flow
tme
divid
total
expiratori
time
e
tmete
ratio
morri
lane
shown
decreas
tmete
ratio
correl
lower
lung
function
patient
progress
chronic
obstruct
lung
diseas
infant
studi
martinez
et
al
develop
lri
wheez
least
one
infect
difler
preinfect
lung
function
infant
lri
infect
wheez
tabl
howev
infant
wheez
respiratori
infect
diminish
tmete
valu
reduc
expiratori
system
conduct
measur
prior
wheez
infect
data
suggest
alter
lung
function
compat
reduc
airway
conduct
slow
respiratori
system
time
constant
preced
predict
wheez
respiratori
infect
infant
furthermor
appear
given
child
respons
infect
determin
infect
also
preexist
lung
function
taussig
et
al
also
note
lower
level
lung
function
predispos
wheez
lri
oppos
infect
per
se
precis
natur
predisposit
remain
defin
may
lie
airway
geometri
airwayparenchym
interact
mucos
smooth
muscl
respons
furthermor
pulmonarystructur
predisposit
may
enhanc
exagger
ige
respons
viral
infect
result
inflamm
sever
wheez
hospit
sinc
major
infant
develop
wheez
lri
wheez
throughout
life
like
pulmonari
function
abnorm
favour
wheez
viral
infect
modifi
growth
develop
lung
longterm
outcom
seem
close
link
persist
ongo
airway
damag
bronchospasm
associ
develop
atopi
true
clinic
asthma
possibl
definit
insight
relationship
wheez
earli
respiratori
infect
later
develop
asthma
come
uniqu
identifi
number
factor
affect
wheez
age
year
relationship
wheez
year
age
studi
popul
previous
report
consist
newborn
enrol
followup
inform
year
age
key
assess
infanc
includ
cordserum
g
e
level
pulmonari
function
test
lower
respiratori
tract
ill
occur
measur
serum
g
e
month
age
questionnair
complet
children
parent
child
year
old
children
classifi
four
group
wheez
transient
wheez
lateonset
wheez
persist
wheez
tabl
opposit
year
age
serum
ige
pulmonari
function
test
allergi
skin
test
repeat
factor
assess
relationship
histori
wheez
year
age
children
least
one
lower
respiratori
ill
wheez
first
year
life
wheez
age
year
children
diminish
airway
function
age
year
year
age
like
mother
smoke
mother
asthma
evid
atopi
ie
elev
serum
g
e
skin
test
reactiv
addit
wheez
age
year
wheez
age
year
wheez
year
age
year
age
lateonset
wheez
persist
wheez
like
mother
histori
asthma
elev
serum
g
e
level
diminish
lung
function
year
age
tabl
g
g
u
g
u
g
qj
rg
g
n
c
n
j
h
j
u
b
u
oj
g
toe
g
n
u
u
u
w
g
u
g
u
la
u
co
g
co
u
vh
n
v
gh
g
th
u
n
u
u
vh
g
g
u
g
g
co
v
h
u
c
g
u
g
co
u
vh
c
g
n
u
u
g
co
u
g
co
number
conclus
drawn
prospect
longitudin
studi
infant
wheez
earli
life
transient
condit
predilect
wheez
respiratori
infect
associ
diminish
lung
function
children
enhanc
risk
asthma
allerg
diseas
later
life
group
particular
interest
regard
role
respiratori
infect
develop
asthma
infant
either
persist
lateonset
wheez
children
asthma
age
year
appear
predisposit
asthma
indic
matern
histori
asthma
elev
serum
g
e
level
first
year
life
moreov
children
reduc
lung
function
year
age
role
respiratori
infect
actual
develop
asthma
predisposit
asthma
less
clear
respiratori
infect
relationship
subsequ
develop
asthma
issu
remain
fulli
elucid
insight
factor
may
determin
host
respons
viral
infect
subsequ
effect
lung
function
gain
anim
studi
sork
et
al
infect
neonat
rat
sendai
viru
week
afer
infect
rat
infect
lower
valu
increas
lung
resist
compar
control
furthermor
infect
anim
sensit
aerosol
methacholin
lung
histolog
infect
anim
reveal
increas
number
bronchiolar
mast
cell
eosinophil
subsequ
studi
investig
found
rat
strain
ie
brown
norway
suscept
effect
viru
like
persist
alter
lung
function
studi
anim
model
compat
observ
martinez
et
al
indic
mani
factor
determin
eventu
influenc
respiratori
infect
airway
function
ie
wheez
bronchial
hyperrespons
includ
predisposit
produc
ige
antibodi
howev
need
clarifi
mechan
respiratori
virus
interact
igedepend
factor
promot
asthmalik
pictur
decad
clinician
associ
asthma
exacerb
respiratori
infect
prospect
studi
becam
appar
viral
bacteri
upper
respiratori
infect
uri
trigger
asthma
attack
use
sensit
techniqu
identifi
respiratori
virus
relationship
respiratori
infect
particularli
viral
uri
asthma
becom
even
convinc
import
earli
studi
mcintosh
cowork
prospect
studi
young
children
age
year
sever
asthma
aetiolog
uri
care
evalu
confirm
cultur
serolog
test
viral
antibodi
titr
year
confirm
viral
respiratori
infect
episod
wheez
episod
wheez
occur
relationship
viral
respiratori
infect
rsv
preval
like
provok
asthma
respiratori
bacteria
haemophilu
influen
ae
streptococcu
pneumonia
j
haemolyt
streptococcu
staphylococcu
aureu
also
cultur
presenc
correl
asthma
attack
prospect
outpati
studi
univers
wisconsin
evalu
children
age
year
histori
four
asthma
attack
associ
respiratori
ill
previou
year
detail
clinic
record
profil
child
asthma
sever
substanti
biweekli
examin
asthma
exacerb
appar
uri
addit
bacteria
viru
cultur
collect
asthma
symptom
care
quantit
children
experienc
episod
asthma
occur
conjunct
symptomat
respiratori
infect
confirm
viral
aetiolog
cultur
andor
serum
haemagglutin
titr
studi
rhinoviru
frequent
identifi
viru
associ
wheez
patient
episod
asymptomat
viral
infect
asthma
worsen
one
episod
wheez
coincid
bacteri
infect
extend
observ
determin
relationship
differ
respiratori
infect
wheez
mertsola
et
al
identifi
patient
age
year
recurr
attack
wheez
observ
period
patient
experienc
episod
upper
lower
respiratori
symptom
episod
laboratori
evid
viral
mycoplasma
infect
found
relev
discuss
observ
wheez
occur
laboratoryconfirm
viral
respiratori
infect
moreov
children
wheez
respiratori
infect
onethird
admit
hospit
sever
dyspnoea
final
agent
isol
coronaviru
rhinoviru
frequent
isol
also
evid
virus
caus
wheez
respiratori
tract
infect
may
age
depend
exampl
infant
wheez
rsv
older
children
exacerb
asthma
rhinoviru
extend
observ
duff
colleagu
examin
relationship
viral
infect
passiv
smoke
exposur
ige
antibodi
inhal
allergen
infant
children
treat
acut
episod
wheez
emerg
depart
investig
identifi
subject
age
month
year
age
control
patient
age
month
year
age
seen
paediatr
emerg
room
acut
wheez
children
less
year
age
virus
detect
cultur
nasal
wash
patient
commonli
identifi
viru
rsv
posit
viru
cultur
rsv
note
appropri
agematch
control
contrast
nasal
wash
yield
posit
cultur
children
year
age
present
acut
wheez
howev
frequent
identifi
respiratori
viru
age
group
rhinoviru
investig
evalu
risk
factor
associ
wheez
viral
infect
interest
insight
correl
note
tabl
children
less
year
age
coexist
allerg
diseas
risk
factor
rather
passiv
exposur
cigarett
smoke
indic
urinari
cotinin
valu
jugml
risk
factor
wheez
profil
children
year
age
wheez
viral
uri
quit
differ
children
presenc
allergi
ie
posit
radioallergosorb
test
rast
valu
passiv
cigarett
smoke
exposur
domin
risk
factor
wheez
viral
respiratori
infect
observ
duff
et
al
confirm
previou
inform
rsv
major
viral
infect
caus
wheez
infant
wherea
rhinoviru
caus
respiratori
infect
associ
wheez
older
children
moreov
wheez
infant
increas
presenc
allerg
diseas
rather
made
probabl
cigarett
smoke
exposur
present
older
child
allergi
major
risk
factor
wheez
rhinoviru
data
also
impli
uniqu
relationship
may
exist
rhinoviru
allergi
interact
may
influenc
develop
wheez
particular
respiratori
viru
detect
respiratori
virus
particularli
rhinoviru
cultur
difficult
fastidi
virus
cultur
consequ
determin
associ
rhinoviru
infect
provoc
asthma
use
viru
cultur
may
give
underestim
true
frequenc
cold
asthma
johnston
ef
al
develop
polymeras
chain
reaction
pcr
assay
detect
picornaviru
infect
approach
increas
sensit
thu
greater
likelihood
detect
caus
virus
relationship
clinic
symptom
cold
eventu
influenc
asthma
use
pcr
technolog
along
cultur
johnston
colleagu
studi
associ
upper
lower
respiratori
viral
infect
acut
exacerb
asthma
schoolag
children
children
year
age
follow
period
children
parent
record
peak
expiratori
flow
rate
twice
daili
daili
upper
lower
respiratori
tract
symptom
score
sever
onset
respiratori
symptom
signific
fall
peak
expiratori
flow
valu
child
visit
investig
nasal
aspir
obtain
viru
detect
number
import
observ
johnston
colleagu
larg
studi
first
season
pattern
appear
respiratori
symptom
chang
peak
flow
valu
asthma
patient
month
n
v
e
b
e
r
decemb
april
appear
frequent
time
cold
asthma
exacerb
second
respiratori
virus
detect
approxim
episod
respiratori
tract
symptom
fall
peak
flow
tabl
third
rhinoviru
frequent
detect
microorgan
constitut
virus
detect
tabl
fourth
sever
asthma
symptom
mani
subject
sever
observ
other
appar
rhinoviru
caus
common
cold
respiratori
infect
like
exacerb
wheez
individu
exist
asthma
possibl
relationship
simpli
reflect
fact
rhinoviru
common
caus
infecti
respiratori
symptom
ie
common
cold
howev
associ
may
also
mean
contrast
observ
children
relationship
respiratori
infect
episod
wheez
strike
adult
children
adult
evalu
respiratori
virus
frequent
identifi
episod
asthma
children
year
age
compar
adult
eight
adult
subject
evalu
minor
et
alp
three
document
viru
infect
increas
wheez
although
explan
find
clear
like
asthma
flare
diflficult
sharpli
delin
pattern
wheez
often
appear
chronic
rather
episod
adult
similarli
hudgel
cowork
evalu
adult
asthma
patient
period
episod
asthma
record
eight
could
document
viral
url
although
clinic
appar
viral
respiratori
infect
precipit
asthma
adult
rel
frequenc
appear
less
children
anoth
studi
huhti
et
al
evalu
adult
admit
hospit
asthma
exacerb
viral
detect
rate
rsv
parainfluenza
influenza
frequent
isol
use
viru
cultur
pcr
techniqu
nicholson
cowork
evalu
relationship
symptomat
cold
asthma
exacerb
adult
asthmat
subject
investig
found
symptomat
cold
report
episod
symptom
wheez
chest
tight
breathless
laboratoryprov
episod
nonbacteri
respiratori
infect
reduct
peak
flow
litremin
infect
rhinovirus
coronavirus
influenza
rsv
parainfluenza
chlamydia
associ
object
measur
airflow
limit
find
nicholson
et
al
evid
import
respiratori
virus
particularli
rhinoviru
asthma
exacerb
episod
sever
occur
adult
therefor
evid
exist
underscor
import
viral
respiratori
infect
asthma
exacerb
patient
age
littl
evid
bacteri
respiratori
infect
sinus
provok
asthma
berman
et
al
perform
transtrach
aspir
adult
patient
asthma
infecti
exacerb
bacteria
cultur
transtrach
aspir
spars
importantli
correl
clinic
ill
moreov
transtrach
aspir
normal
subject
without
respiratori
infect
yield
similar
degre
bacteri
colon
common
complic
cold
develop
sinus
propos
factor
worsen
asthma
although
associ
paranas
sinus
bronchial
asthma
long
observ
conceiv
sinus
asthma
may
coexist
complic
respiratori
infect
howev
feel
aetiolog
relationship
exist
sinus
asthma
although
observ
associ
intrigu
clinic
import
addit
studi
need
clarifi
sinus
may
influenc
asthma
number
mechan
propos
explain
viral
respiratori
infect
provok
asthma
tabl
evalu
possibl
import
realiz
effect
respiratori
virus
airway
function
depend
upon
mani
factor
includ
subject
gender
environment
factor
cigarett
smoke
exposur
age
baselin
lung
function
atop
statu
along
particular
respiratori
viru
howev
convinc
evid
rhinovirus
predomin
respiratori
infect
provok
wheez
patient
asthma
exist
allerg
diseas
appear
import
risk
factor
therefor
propos
respiratori
virus
particularli
rhinovirus
may
interact
factor
contribut
determin
exist
allerg
airway
diseas
enhanc
exist
bronchial
inflamm
endresult
eflect
viru
underli
alter
epitheli
function
alter
autonom
nervou
system
regul
airway
smooth
muscl
function
enhanc
allerg
inflamm
enhanc
eosinophil
recruit
eosinophil
infiltr
airway
gener
proinflammatori
cytokin
enhanc
inflammatori
mediat
releas
alter
function
sinopulmonari
reflex
product
virusspecif
ige
antibodi
allerg
airway
diseas
enhanc
likelihood
wheez
although
factor
like
particip
process
follow
discuss
examin
respiratori
virus
either
influenc
igedepend
event
promot
develop
allerg
inflamm
welliv
et
al
test
children
less
month
age
document
rsv
infect
presenc
igespecif
antibodi
infect
viru
clinic
pattern
ill
divid
four
group
upper
respiratori
tract
ill
b
pneumonia
without
wheez
c
pneumonia
wheez
wheez
bronchiol
nasal
secret
patient
measur
igespecif
antibodi
rsv
rsv
ige
antibodi
titr
compar
patient
clinic
ill
g
e
titr
rsv
highest
patient
evid
airway
obstruct
eg
pneumoniawheez
bronchiol
parainfluenza
virusspecif
ige
respons
also
examin
individu
upper
respiratori
ill
alon
bronchiol
welliv
et
al
parainfluenzaspecif
ige
antibodi
detect
bronchiol
upper
respiratori
diseas
alon
studi
suggest
respiratori
virus
stimul
igespecif
antibodi
respons
degre
occur
associ
clinic
manifest
upper
vs
lower
airway
diseas
evalu
signific
virusspecif
g
e
antibodi
welliv
et
al
prospect
monitor
infant
month
initi
episod
bronchiol
infant
undetect
titr
rsv
ige
subsequ
episod
document
wheez
contrast
children
high
rsv
g
e
antibodi
titr
continu
experi
wheez
evalu
year
later
portion
subject
evalu
year
age
underw
skin
test
common
inhal
allergen
pulmonari
function
test
methacholin
provoc
determin
bronchial
respons
entir
studi
group
rsv
g
e
respons
evalu
relationship
famili
histori
asthma
passiv
smoke
exposur
number
recurr
wheez
episod
number
posit
skin
test
degre
airway
respons
methacholin
investig
found
associ
exist
rsv
ige
respons
develop
wheez
follow
bronchiol
natur
howev
associ
rsv
g
e
antibodi
recurr
wheez
unclear
therefor
consequ
initi
g
e
respons
infect
viru
regard
longterm
influenc
airway
function
develop
asthma
unresolv
although
rhinovirus
emerg
common
respiratori
infect
caus
asthma
exacerb
number
paradox
relationship
first
rhinovirus
infect
appear
local
upper
airway
identif
rhinoviru
cultur
lower
airway
unusuap
pneumon
infiltr
rare
second
even
though
rhinovirus
infect
airway
epithelium
inflammatori
respons
often
unimpress
exampl
fraenkel
cowork
perform
nasal
biopsi
experiment
rhinoviru
infect
normal
atop
group
signific
chang
inflammatori
cell
cold
convalesc
period
compar
baselin
valu
thu
immunohistochem
analysi
rhinovirusinfect
upper
airway
reveal
inflamm
third
rhinoviru
infect
tend
selflimit
later
sequela
rare
therefor
mechan
lower
airway
dysfunct
readili
explain
overzeal
inflammatori
airway
respons
particular
viru
frequent
associ
asthma
respiratori
infect
particular
rhinoviru
ill
may
relat
frequenc
rhinovirus
caus
cold
frequenc
howev
explain
appar
seriou
lower
airway
event
associ
rhinoviru
infect
subject
asthma
major
goal
current
research
establish
particular
class
respiratori
virus
affect
lower
airway
profoundli
effect
last
week
beyond
acut
respiratori
ill
initi
seri
experi
evalu
effect
respiratori
infect
airway
respons
infect
subject
rhinoviru
experiment
determin
effect
varieti
airway
function
patient
select
studi
evalu
three
separ
occas
baselin
acut
infect
recoveri
particular
interest
effect
infect
immedi
latephas
allerg
respons
lar
inhal
antigen
patient
rhinoviru
respiratori
infect
time
studi
acut
rhinoviru
respiratori
infect
airway
respons
histamin
significantli
increas
baselin
valu
likewis
acut
airway
reactiv
inhal
antigen
increas
chang
airway
respons
histamin
antigen
similar
suggest
effect
respiratori
infect
respons
antigen
relat
alter
nonspecif
bronchial
reactiv
prior
rhinoviru
inocul
patient
lar
inhal
antigen
howev
acut
respiratori
infect
patient
experienc
latephas
airway
obstruct
inhal
antigen
challeng
furthermor
evalu
recoveri
period
week
rhinoviru
inocul
five
seven
patient
avail
test
still
lar
inhal
antigen
observ
indic
rhinoviru
respiratori
infect
increas
airway
respons
also
chang
pattern
airway
respons
inhal
antigen
promot
develop
allerg
inflamm
indic
develop
lar
recoveri
pattern
airway
hyperrespons
follow
viral
respiratori
infect
also
evalu
although
increas
airway
respons
still
detect
week
rhinoviru
inocul
trend
toward
recoveri
reaction
inhal
histamin
respons
antigen
howev
alreadi
discuss
increas
frequenc
lar
antigen
still
note
week
viral
infect
suggest
viral
respiratori
infect
greater
possibl
last
effect
factor
particip
develop
lar
virusassoci
airway
hyperrespons
multifactori
process
involv
complex
interplay
igedepend
reaction
epitheli
activ
damag
autonom
nervou
system
dysfunct
particular
interest
relev
discuss
enhanc
allerg
inflamm
igemedi
reaction
tissu
respons
skin
nose
airway
influenc
g
e
sensit
mast
cell
basophil
releas
bronchospast
inflammatori
mediat
sensit
cell
respons
target
organ
asthma
bronchial
smooth
muscl
evalu
effect
respiratori
virus
facet
immedi
hypersensit
respons
ie
mediat
releas
basophil
histamin
secret
determin
vitro
model
system
peripher
blood
mononuclear
cell
incub
influenza
viru
effect
exposur
upon
igedepend
basophil
histamin
releas
leukotrien
lt
measur
follow
incub
viru
histamin
secret
enhanc
defin
role
tcell
process
tcell
remov
magnet
head
separ
antibodi
absenc
tcell
viru
incub
enhanc
histamin
releas
furthermor
analysi
virustr
peripher
blood
mononuclear
cell
reveal
viru
caus
gener
interferon
ifn
find
suggest
tcell
cytokin
product
ifni
may
play
integr
role
process
respiratori
virus
enhanc
basophil
histamin
releas
like
affect
cell
function
use
bronchoscopi
lavag
biopsi
provid
direct
assess
analysi
airway
mediat
histolog
inflammatori
event
asthma
use
fibreopt
bronchoscopi
perform
segment
bronchoprovoc
antigen
bronchoalveolar
lavag
bal
assess
immedi
late
respons
airway
antigen
studi
effect
rhinoviru
ill
allerg
event
conduct
experi
bronchoscop
introduc
airway
bronchial
segment
identifi
allergen
administ
directli
airway
mucosa
immedi
respons
antigen
character
brisk
rise
mast
cell
mediat
lavag
previous
allergenchalleng
segment
perform
h
later
highli
cellular
eosinophilrich
respons
detect
base
previou
observ
rhinoviru
infect
increas
bronchial
respons
lar
inhal
antigen
use
segment
antigen
challeng
lavag
test
hypothesi
rhinoviru
upper
respiratori
ill
may
enhanc
lower
airway
allerg
inflammatori
respons
antigen
histamin
releas
airway
immedi
follow
antigen
challeng
repres
mast
cell
activ
found
histamin
releas
airway
immedi
follow
local
antigen
challeng
significantli
potenti
rhinoviru
infect
tabl
observ
indic
acut
rhinoviru
ill
enhanc
airway
mast
cell
mediat
releas
find
similar
earlier
report
indic
effect
infect
mast
cell
activ
interestingli
relev
earlier
observ
rhinoviru
effect
airway
function
longlast
enhanc
histamin
releas
antigen
still
present
week
acut
infect
time
individu
symptomfre
find
suggest
viral
effect
allerg
respons
persist
week
beyond
acut
ill
persist
explain
longlast
effect
airway
function
asthma
cold
lavag
perform
h
antigen
challeng
characterist
often
dramat
influx
eosinophil
lavag
fluid
found
signific
enhanc
eosinophil
recruit
airway
h
antigen
subject
acut
rhinoviru
infect
fig
like
observ
enhanc
persist
histamin
releas
greater
eosinophil
recruit
antigen
challeng
note
acut
infect
respiratori
viru
effect
persist
recoveri
period
week
later
find
suggest
possibl
explan
increas
lar
antigen
note
acut
rhinoviru
infect
allergen
exposur
rhinoviru
infect
associ
enhanc
eosinophil
recruit
airway
allerg
inflamm
lar
like
occur
fraenkel
colleagu
provid
addit
insight
mechan
rhinoviru
infect
promot
airway
inflamm
likelihood
increas
asthma
cold
normal
asthmat
subject
recruit
studi
investig
obtain
bronchial
mucos
biopsi
acut
experiment
rhinoviru
infect
evalu
chang
inflammatori
cell
infiltr
due
viru
airway
respons
increas
airway
respons
histamin
cold
associ
increas
submucos
lymphocyt
increas
epitheli
eosinophil
experiment
cold
fig
asthmat
compar
normal
subject
increas
mucos
eosinophil
persist
convalesc
period
although
chang
variou
featur
immunohistolog
dramat
follow
pattern
consist
find
enhanc
eosinophil
recruit
airway
correl
alter
lung
physios
collect
evid
airway
physiolog
rhinoviru
infect
enhanc
bronchial
respons
histolog
featur
allerg
inflamm
ie
greater
likelihood
lar
occur
furthermor
studi
directli
sampl
lower
airway
evid
increas
eosinophil
recruit
mucos
eosinophilia
time
rhinoviru
infect
abnorm
persist
week
beyond
acut
ill
find
indic
rhinoviru
infect
perpetu
featur
allerg
inflamm
may
thu
explain
increas
likelihood
asthma
question
remain
answer
concern
mechan
rhinoviru
infect
enhanc
allerg
airway
inflamm
use
nasal
mucos
respons
rhinoviru
surrog
airway
respons
rhinoviru
fraenkel
et
al
biopsi
nasal
tissu
acut
rhinoviru
infect
mast
cell
eosinophil
lymphocyt
neutrophil
identifi
appropri
monoclon
antibodi
signific
chang
number
inflammatori
cell
present
cold
convalesc
period
compar
baselin
valu
although
observ
contrast
biopsi
find
lower
airway
chang
airway
histolog
dramat
find
suggest
mechan
ie
enhanc
mediat
releas
like
cytokin
gener
respons
chang
airway
function
cold
studi
segment
antigen
challeng
lavag
fluid
analys
tumour
necrosi
factor
tnf
lavag
sampl
obtain
h
antigen
challeng
signific
rise
tnfa
chang
note
normal
control
allerg
subject
u
r
find
rais
possibl
rhinoviru
infect
caus
secret
tnfa
enhanc
secret
cytokin
occur
allerg
subject
featur
allerg
inflamm
like
occur
find
also
rais
possibl
rhinoviru
directli
stimul
cytokin
product
linden
et
measur
ifni
interleukin
il
granulocytemacrophag
colonystimul
factor
gmcsf
nasal
secret
subject
allerg
rhiniti
experiment
coronaviru
cold
increas
ifni
cytokin
increas
ifni
expect
repres
antivir
respons
viru
howev
ifni
proinflammatori
effect
ie
promot
adhes
protein
express
enhanc
surviv
eosinophil
moreov
observ
indic
rhinoviru
infect
stimul
cytokin
product
vivo
extend
observ
live
rhinoviru
incub
human
mononuclear
cell
lung
macrophag
gern
et
al
found
cell
took
viru
replic
insid
cell
none
less
rhinoviru
abl
activ
monocyt
airway
macrophag
caus
secret
tnfa
observ
indic
rhinoviru
caus
synthesi
releas
proinflammatori
cytokin
may
occur
independ
cell
infect
identifi
mechan
rhinoviru
promot
allerg
inflamm
essenti
immun
respons
viru
establish
factor
cell
involv
promot
allerg
inflamm
identifi
determin
effect
rhinoviru
immun
respons
establish
receptor
major
rhinoviru
strain
intercellular
adhes
molecul
icam
rhinoviru
strain
use
lowdens
lipoprotein
receptor
interact
rhinoviru
receptor
first
step
host
respons
viru
inform
found
major
rhinoviru
rhinoviru
bind
mononuclear
cell
via
receptor
bind
occur
predominantli
monocyt
lymphocyt
rhinoviru
incub
mixtur
monocyt
lymphocyt
follow
event
occur
larg
increas
number
cell
express
earli
activ
marker
cell
isol
analys
found
increas
express
mrna
ifni
vitro
observ
suggest
rhinoviru
activ
monocyt
gener
cytokin
stimul
lymphocyt
activ
lymphocyt
cd
gener
varieti
cytokin
includ
ifni
although
ifni
normal
import
antivir
activ
also
possess
number
proinflammatori
function
includ
increas
express
endotheli
epitheli
receptor
rhinoviru
promot
eosinophil
surviv
therefor
addit
activ
small
number
rhinovirusspecif
lymphocyt
rhinoviru
caus
nonspecif
activ
lymphocyt
gener
cytokin
monocyt
cytokin
turn
promot
either
viral
elimin
inflamm
perhap
sequela
particular
respons
like
allerg
inflamm
alreadi
exist
extend
possibl
einarsson
cowork
evalu
effect
respiratori
virus
stromal
cell
product
extrem
cation
cytokin
capac
induc
airway
hyperrespons
murin
lung
investig
found
rhinovirus
along
rsv
parainfluenza
potent
stimul
contrast
cytomegaloviru
adenoviru
weaker
activ
virus
associ
asthma
exacerb
furthermor
increas
level
found
nasal
secret
children
uri
like
appear
nasal
aspir
children
reactiv
airway
diseas
observ
anoth
exampl
mechan
respiratori
virus
enhanc
airway
inflamm
gener
specif
cytokin
thu
increas
likelihood
asthma
cold
use
mous
model
coyl
et
al
character
immun
respons
viru
peptid
result
cytokin
pattern
investig
found
bystand
immun
respons
ovalbumin
switch
peptidespecif
cd
tcell
lung
produc
cd
tcell
challeng
via
airway
viru
peptid
signific
eosinophil
infiltr
induc
furthermor
vitro
studi
indic
could
switch
virusspecif
tcell
product
result
demonstr
network
allerg
eosinophil
inflamm
occur
respiratori
viral
infect
mechan
would
impair
tcell
respons
less
ifni
product
thu
delay
viru
clearanc
observ
indic
network
promot
allerg
inflamm
also
mechan
viru
particl
may
persist
extend
period
studi
human
coyl
et
al
mous
suggest
possibl
link
eosinophil
airway
chang
viral
respiratori
infect
garofalo
et
alp
sampl
nasolaryng
sampl
children
rsv
respiratori
ill
eosinophil
protein
eosinophil
cation
protein
significantli
increas
sampl
children
bronchiol
compar
subject
upper
airway
diseas
rsv
pneumonia
wheez
data
suggest
eosinophil
activ
rsv
may
caus
airway
injuri
presenc
wheez
extend
find
vitro
experi
kimpen
et
al
incub
isol
human
eosinophil
rsv
rsv
directli
activ
eosinophil
releas
superoxid
furthermor
incub
eosinophil
rsv
prime
cell
activ
gener
inflammatori
mediat
observ
indic
airwayact
viru
case
rsv
interact
eosinophil
caus
releas
proinflammatori
mediat
indic
author
effect
viru
could
play
role
pathogenesi
rsv
bronchiol
may
also
import
develop
longterm
bronchial
hyperrespons
associ
viral
infect
also
possibl
respiratori
virus
rhino
viru
may
similar
effect
cold
mechan
involv
develop
airway
hyperrespons
airway
obstruct
recurr
wheez
viral
respiratori
infect
yet
fulli
appreci
none
less
current
evid
indic
virus
product
virusinfect
cell
influenc
inflammatori
properti
potenti
mani
cell
precis
effect
viru
translat
increas
airway
injuri
respons
obstruct
requir
work
mechan
interact
establish
improv
understand
asthma
pathogenesi
treatment
